Volatile versus Total Intravenous Anesthesia for Cancer Prognosis in Patients Having Digestive Cancer Surgery
Background Previous experimental and clinical studies have shown that anesthetic agents have varying effects on cancer prognosis; however, the results were inconsistent among these studies. The authors compared overall and recurrence-free survival in patients given volatile or intravenous anesthesia...
Saved in:
Published in | Anesthesiology (Philadelphia) Vol. 133; no. 4; pp. 764 - 773 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
01.10.2020
|
Online Access | Get full text |
Cover
Loading…
Abstract | Background
Previous experimental and clinical studies have shown that anesthetic agents have varying effects on cancer prognosis; however, the results were inconsistent among these studies. The authors compared overall and recurrence-free survival in patients given volatile or intravenous anesthesia for digestive tract cancer surgery.
Methods
The authors selected patients who had elective esophagectomy, gastrectomy, hepatectomy, cholecystectomy, pancreatectomy, colectomy, and rectal cancer surgery from July 2010 to March 2018 using the Japanese Diagnosis Procedure Combination database. Patients were divided into a volatile anesthesia group (desflurane, sevoflurane, or isoflurane with/without nitrous oxide) and a propofol-based total intravenous anesthesia group. The authors hypothesized that total intravenous anesthesia is associated with greater overall and recurrence-free survival than volatile anesthesia. Subgroup analyses were performed for each type of surgery.
Results
The authors identified 196,303 eligible patients (166,966 patients in the volatile anesthesia group and 29,337 patients in the propofol-based total intravenous anesthesia group). The numbers (proportions) of death in the volatile anesthesia and total intravenous anesthesia groups were 17,319 (10.4%) and 3,339 (11.4%), respectively. There were no significant differences between the two groups in overall survival (hazard ratio, 1.02; 95% CI, 0.98 to 1.07; P = 0.28) or recurrence-free survival (hazard ratio, 0.99; 95% CI, 0.96 to 1.03; P = 0.59), whereas instrumental variable analyses showed a slight difference in recurrence-free survival (hazard ratio, 0.92; 95% CI, 0.87 to 0.98; P = 0.01). Subgroup analyses showed no significant difference in overall or recurrence-free survival between the groups in any type of surgery.
Conclusions
Overall and recurrence-free survival were similar between volatile and intravenous anesthesia in patients having digestive tract surgery. Selection of the anesthetic approach for these patients should be based on other factors.
Editor’s Perspective
What We Already Know about This Topic
What This Article Tells Us That Is New |
---|---|
AbstractList | Background
Previous experimental and clinical studies have shown that anesthetic agents have varying effects on cancer prognosis; however, the results were inconsistent among these studies. The authors compared overall and recurrence-free survival in patients given volatile or intravenous anesthesia for digestive tract cancer surgery.
Methods
The authors selected patients who had elective esophagectomy, gastrectomy, hepatectomy, cholecystectomy, pancreatectomy, colectomy, and rectal cancer surgery from July 2010 to March 2018 using the Japanese Diagnosis Procedure Combination database. Patients were divided into a volatile anesthesia group (desflurane, sevoflurane, or isoflurane with/without nitrous oxide) and a propofol-based total intravenous anesthesia group. The authors hypothesized that total intravenous anesthesia is associated with greater overall and recurrence-free survival than volatile anesthesia. Subgroup analyses were performed for each type of surgery.
Results
The authors identified 196,303 eligible patients (166,966 patients in the volatile anesthesia group and 29,337 patients in the propofol-based total intravenous anesthesia group). The numbers (proportions) of death in the volatile anesthesia and total intravenous anesthesia groups were 17,319 (10.4%) and 3,339 (11.4%), respectively. There were no significant differences between the two groups in overall survival (hazard ratio, 1.02; 95% CI, 0.98 to 1.07; P = 0.28) or recurrence-free survival (hazard ratio, 0.99; 95% CI, 0.96 to 1.03; P = 0.59), whereas instrumental variable analyses showed a slight difference in recurrence-free survival (hazard ratio, 0.92; 95% CI, 0.87 to 0.98; P = 0.01). Subgroup analyses showed no significant difference in overall or recurrence-free survival between the groups in any type of surgery.
Conclusions
Overall and recurrence-free survival were similar between volatile and intravenous anesthesia in patients having digestive tract surgery. Selection of the anesthetic approach for these patients should be based on other factors.
Editor’s Perspective
What We Already Know about This Topic
What This Article Tells Us That Is New BACKGROUNDPrevious experimental and clinical studies have shown that anesthetic agents have varying effects on cancer prognosis; however, the results were inconsistent among these studies. The authors compared overall and recurrence-free survival in patients given volatile or intravenous anesthesia for digestive tract cancer surgery. METHODSThe authors selected patients who had elective esophagectomy, gastrectomy, hepatectomy, cholecystectomy, pancreatectomy, colectomy, and rectal cancer surgery from July 2010 to March 2018 using the Japanese Diagnosis Procedure Combination database. Patients were divided into a volatile anesthesia group (desflurane, sevoflurane, or isoflurane with/without nitrous oxide) and a propofol-based total intravenous anesthesia group. The authors hypothesized that total intravenous anesthesia is associated with greater overall and recurrence-free survival than volatile anesthesia. Subgroup analyses were performed for each type of surgery. RESULTSThe authors identified 196,303 eligible patients (166,966 patients in the volatile anesthesia group and 29,337 patients in the propofol-based total intravenous anesthesia group). The numbers (proportions) of death in the volatile anesthesia and total intravenous anesthesia groups were 17,319 (10.4%) and 3,339 (11.4%), respectively. There were no significant differences between the two groups in overall survival (hazard ratio, 1.02; 95% CI, 0.98 to 1.07; P = 0.28) or recurrence-free survival (hazard ratio, 0.99; 95% CI, 0.96 to 1.03; P = 0.59), whereas instrumental variable analyses showed a slight difference in recurrence-free survival (hazard ratio, 0.92; 95% CI, 0.87 to 0.98; P = 0.01). Subgroup analyses showed no significant difference in overall or recurrence-free survival between the groups in any type of surgery. CONCLUSIONSOverall and recurrence-free survival were similar between volatile and intravenous anesthesia in patients having digestive tract surgery. Selection of the anesthetic approach for these patients should be based on other factors. EDITOR’S PERSPECTIVE |
Author | Makito, Kanako Matsui, Hiroki Fushimi, Kiyohide Yasunaga, Hideo |
Author_xml | – sequence: 1 givenname: Kanako surname: Makito fullname: Makito, Kanako – sequence: 2 givenname: Hiroki surname: Matsui fullname: Matsui, Hiroki – sequence: 3 givenname: Kiyohide surname: Fushimi fullname: Fushimi, Kiyohide – sequence: 4 givenname: Hideo surname: Yasunaga fullname: Yasunaga, Hideo |
BookMark | eNpdUMtKA0EQHETBJPoHHuboZeM893EM8ZFA0IDR69LZ9K4jm5k4s1nI3zshCmJfii6qi64aknPrLBJyw9mYsyK7myyex-zPSKXYGRlwLfKE80yfk8GRTSQT4pIMQ_iMa6ZlPiDbd9dCZ1qkPfqwD3TlOmjp3HYeerQuMhOLofvAYIDWztMp2Ao9XXrXWBdMoMbSZbRA2wU6g97Yht6bJt6YHn_Vr3vfoD9ckYsa2oDXPzgib48Pq-ksWbw8zaeTRVKJQrBEpUVa6YzzdSGVkAo4pFyqtQAQMpd6AxtQNaaYsUrWKgbhEXOd5ZjrNQo5Ircn3513X_v4Srk1ocK2BYsxUimUErlSmWZRqk7SyrsQPNblzpst-EPJWXlst4ztlv_bld9c928z |
CitedBy_id | crossref_primary_10_1097_MD_0000000000029169 crossref_primary_10_1016_j_bja_2022_03_019 crossref_primary_10_3389_fonc_2021_686294 crossref_primary_10_3389_fonc_2024_1397197 crossref_primary_10_1016_j_heliyon_2024_e24791 crossref_primary_10_1016_j_biopha_2021_111991 crossref_primary_10_1097_ACO_0000000000001261 crossref_primary_10_1186_s12871_022_01703_8 crossref_primary_10_1007_s12630_023_02653_6 crossref_primary_10_5492_wjccm_v13_i2_92751 crossref_primary_10_1097_ALN_0000000000004309 crossref_primary_10_1111_aas_13791 crossref_primary_10_3892_or_2022_8465 crossref_primary_10_1186_s13063_022_06157_4 crossref_primary_10_17085_apm_24041 crossref_primary_10_1097_MD_0000000000030840 crossref_primary_10_3390_cancers15010209 crossref_primary_10_1002_advs_202102079 crossref_primary_10_3390_jcm13103017 crossref_primary_10_1097_ALN_0000000000003804 crossref_primary_10_3389_fonc_2022_759057 crossref_primary_10_1007_s11912_022_01342_9 crossref_primary_10_3389_fonc_2022_960299 crossref_primary_10_3390_cells12202503 crossref_primary_10_1007_s00423_021_02078_z crossref_primary_10_3389_fphar_2021_685265 crossref_primary_10_3724_abbs_2022067 crossref_primary_10_1007_s11605_021_05037_7 crossref_primary_10_1016_j_bja_2023_01_023 crossref_primary_10_1097_ACO_0000000000001274 crossref_primary_10_1177_15330338221121092 crossref_primary_10_1186_s12871_023_02023_1 crossref_primary_10_3389_fonc_2021_788918 crossref_primary_10_1097_ALN_0000000000004132 crossref_primary_10_1590_1806_9282_2024s102 crossref_primary_10_3390_jpm11121358 crossref_primary_10_3389_fmed_2021_658926 crossref_primary_10_3390_cancers13153654 crossref_primary_10_1097_EA9_0000000000000021 crossref_primary_10_1155_2023_7443226 crossref_primary_10_1186_s12871_023_02400_w crossref_primary_10_3389_fphar_2022_1057571 crossref_primary_10_1007_s00540_023_03288_z crossref_primary_10_1016_j_bjao_2022_100005 crossref_primary_10_3389_fonc_2021_793093 crossref_primary_10_3389_fonc_2022_708632 crossref_primary_10_1186_s12957_023_02891_4 crossref_primary_10_1097_ACO_0000000000001002 crossref_primary_10_1097_SLA_0000000000005568 crossref_primary_10_1016_j_addr_2021_05_023 crossref_primary_10_1007_s11912_022_01282_4 crossref_primary_10_3389_fonc_2022_837959 crossref_primary_10_3390_cancers13143390 crossref_primary_10_1097_ALN_0000000000003510 crossref_primary_10_1111_anae_15582 crossref_primary_10_1016_j_bja_2023_07_027 crossref_primary_10_1097_ACO_0000000000001049 crossref_primary_10_1007_s40140_023_00605_w crossref_primary_10_4097_kja_22584 crossref_primary_10_1186_s12871_023_02308_5 crossref_primary_10_3390_curroncol30010091 crossref_primary_10_1186_s13014_022_02000_x crossref_primary_10_4097_kja_22747 crossref_primary_10_1097_ALN_0000000000004119 crossref_primary_10_1177_1073274820965575 |
Cites_doi | 10.1097/MD.0000000000005479 10.1146/annurev.publhealth.19.1.17 10.1186/s12982-018-0069-7 10.1093/bja/aet581 10.1007/s10555-016-9647-8 10.18632/oncotarget.8304 10.1080/03610910902859574 10.1038/bjc.2014.426 10.1016/j.bja.2017.11.066 10.1097/ALN.0000000000000936 10.1093/aje/kwq433 10.1097/ALN.0b013e31829e47fd 10.1007/s10753-013-9671-6 10.2307/2171753 10.1016/j.ejphar.2018.04.009 10.1093/bja/aeu200 10.3892/or.2016.5218 10.1007/s12630-019-01381-0 10.1097/EDE.0000000000000279 10.1016/j.je.2016.09.009 10.3892/or.2017.5514 10.1016/j.jclinane.2017.08.001 10.2147/OTT.S156792 10.1097/ALN.0000000000002491 10.3109/03009734.2014.922649 10.7314/APJCP.2014.15.16.6703 |
ContentType | Journal Article |
DBID | AAYXX CITATION 7X8 |
DOI | 10.1097/ALN.0000000000003440 |
DatabaseName | CrossRef MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 1528-1175 |
EndPage | 773 |
ExternalDocumentID | 10_1097_ALN_0000000000003440 |
GroupedDBID | --- -~X .-D .XZ .Z2 01R 026 0R~ 1CY 1J1 23M 2WC 354 40H 4Q1 4Q2 4Q3 53G 5GY 5RE 5VS 6J9 71W 77Y 7O~ AAAAV AAAXR AAGIX AAHPQ AAIQE AAJCS AAMOA AAMTA AAQKA AARTV AASCR AASOK AASXQ AAUEB AAWTL AAXQO AAYXX ABASU ABBUW ABDIG ABJNI ABOCM ABVCZ ABXVJ ABZAD ACDDN ACEWG ACGFO ACGFS ACILI ACLED ACOAL ACWDW ACWRI ACXJB ACXNZ ADBBV ADGGA ADHPY AE3 AE6 AEBDS AENEX AFDTB AFEXH AFSOK AFUWQ AGINI AHOMT AHQNM AHVBC AHXIK AIJEX AINUH AJIOK AJNWD AJRGT AJZMW AKULP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AWKKM BAWUL BCGUY BOYCO BQLVK BYPQX C45 CITATION CS3 DIK DIWNM E.X EBS EEVPB ERAAH EX3 F2K F2L F2M F2N F5P FCALG FL- GNXGY GQDEL GX1 H0~ HLJTE HZ~ IKREB IKYAY IN~ IPNFZ JF7 JK3 JK8 K-A K-F K8S KD2 KMI L-C L7B N9A N~7 N~B O9- OAG OAH OB3 OBH ODA ODMTH ODZKP OGROG OHH OHYEH OJAPA OK1 OL1 OLB OLG OLH OLL OLU OLV OLW OLY OLZ OPUJH OVD OVDNE OVIDH OVLEI OVOZU OWU OWV OWW OWX OWY OWZ OXXIT P2P RIG RLZ S4R S4S TEORI TR2 TSPGW TWZ V2I W2D W3M WH7 WOQ WOW X3V X3W XXN XYM YFH YOC ZFV ZY1 7X8 ACLDA |
ID | FETCH-LOGICAL-c2920-4696c5711b934234a1a6134b2aa23835dada4fe6e70c3f45381c3f8578e85be23 |
ISSN | 0003-3022 |
IngestDate | Fri Oct 25 00:08:05 EDT 2024 Fri Aug 23 01:45:36 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c2920-4696c5711b934234a1a6134b2aa23835dada4fe6e70c3f45381c3f8578e85be23 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Undefined-1 ObjectType-Feature-3 content type line 23 |
OpenAccessLink | https://pubs.asahq.org/anesthesiology/article-pdf/133/4/764/515065/20201000.0-00020.pdf |
PQID | 2442844750 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_2442844750 crossref_primary_10_1097_ALN_0000000000003440 |
PublicationCentury | 2000 |
PublicationDate | 20201001 |
PublicationDateYYYYMMDD | 2020-10-01 |
PublicationDate_xml | – month: 10 year: 2020 text: 20201001 day: 01 |
PublicationDecade | 2020 |
PublicationTitle | Anesthesiology (Philadelphia) |
PublicationYear | 2020 |
References | Swanson (2021080915435765800_R27) 2015; 26 Lousdal (2021080915435765800_R26) 2018; 15 Yap (2021080915435765800_R10) 2019; 66 Iwasaki (2021080915435765800_R18) 2016; 7 Benzonana (2021080915435765800_R1) 2013; 119 Jiang (2021080915435765800_R4) 2018; 831 Yang (2021080915435765800_R19) 2017; 37 Zheng (2021080915435765800_R24) 2018; 11 Newhouse (2021080915435765800_R14) 1998; 19 Yoo (2021080915435765800_R23) 2019; 130 Desmond (2021080915435765800_R3) 2015; 35 Ciechanowicz (2021080915435765800_R17) 2018; 120 Yang (2021080915435765800_R20) 2017; 37 Liu (2021080915435765800_R8) 2016; 95 Quan (2021080915435765800_R12) 2011; 173 Liu (2021080915435765800_R9) 2014; 15 Yamana (2021080915435765800_R11) 2017; 27 Wigmore (2021080915435765800_R22) 2016; 124 Huang (2021080915435765800_R16) 2014; 111 Soltanizadeh (2021080915435765800_R21) 2017; 42 Baki (2021080915435765800_R7) 2013; 36 Buckley (2021080915435765800_R2) 2014; 113 Suppl 1 Staiger (2021080915435765800_R15) 1997; 65 Austin (2021080915435765800_R13) 2009; 38 Kim (2021080915435765800_R5) 2017; 36 Jaura (2021080915435765800_R6) 2014; 113 Suppl 1 Enlund (2021080915435765800_R25) 2014; 119 |
References_xml | – volume: 95 start-page: e5479 year: 2016 ident: 2021080915435765800_R8 article-title: Effects of propofol and sevoflurane on perioperative immune response in patients undergoing laparoscopic radical hysterectomy for cervical cancer. publication-title: Medicine (Baltimore) doi: 10.1097/MD.0000000000005479 contributor: fullname: Liu – volume: 19 start-page: 17 year: 1998 ident: 2021080915435765800_R14 article-title: Econometrics in outcomes research: The use of instrumental variables. publication-title: Annu Rev Public Health doi: 10.1146/annurev.publhealth.19.1.17 contributor: fullname: Newhouse – volume: 15 start-page: 1 year: 2018 ident: 2021080915435765800_R26 article-title: An introduction to instrumental variable assumptions, validation and estimation. publication-title: Emerg Themes Epidemiol doi: 10.1186/s12982-018-0069-7 contributor: fullname: Lousdal – volume: 113 Suppl 1 start-page: i63 year: 2014 ident: 2021080915435765800_R6 article-title: Differential effects of serum from patients administered distinct anaesthetic techniques on apoptosis in breast cancer cells in vitro: A pilot study. publication-title: Br J Anaesth doi: 10.1093/bja/aet581 contributor: fullname: Jaura – volume: 36 start-page: 159 year: 2017 ident: 2021080915435765800_R5 article-title: Anesthetic technique and cancer recurrence in oncologic surgery: Unraveling the puzzle. publication-title: Cancer Metastasis Rev doi: 10.1007/s10555-016-9647-8 contributor: fullname: Kim – volume: 7 start-page: 26042 year: 2016 ident: 2021080915435765800_R18 article-title: Volatile anaesthetics enhance the metastasis related cellular signalling including CXCR2 of ovarian cancer cells. publication-title: Oncotarget doi: 10.18632/oncotarget.8304 contributor: fullname: Iwasaki – volume: 38 start-page: 1228 year: 2009 ident: 2021080915435765800_R13 article-title: Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research. publication-title: Commun Stat Simul Comput doi: 10.1080/03610910902859574 contributor: fullname: Austin – volume: 111 start-page: 1338 year: 2014 ident: 2021080915435765800_R16 article-title: Prostate cancer cell malignancy via modulation of HIF-1α pathway with isoflurane and propofol alone and in combination. publication-title: Br J Cancer doi: 10.1038/bjc.2014.426 contributor: fullname: Huang – volume: 120 start-page: 368 year: 2018 ident: 2021080915435765800_R17 article-title: Differential effects of sevoflurane on the metastatic potential and chemosensitivity of non-small-cell lung adenocarcinoma and renal cell carcinoma in vitro. publication-title: Br J Anaesth doi: 10.1016/j.bja.2017.11.066 contributor: fullname: Ciechanowicz – volume: 124 start-page: 69 year: 2016 ident: 2021080915435765800_R22 article-title: Long-term survival for patients undergoing volatile versus IV anesthesia for cancer surgery: A retrospective analysis. publication-title: Anesthesiology doi: 10.1097/ALN.0000000000000936 contributor: fullname: Wigmore – volume: 173 start-page: 676 year: 2011 ident: 2021080915435765800_R12 article-title: Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. publication-title: Am J Epidemiol doi: 10.1093/aje/kwq433 contributor: fullname: Quan – volume: 119 start-page: 593 year: 2013 ident: 2021080915435765800_R1 article-title: Isoflurane, a commonly used volatile anesthetic publication-title: Anesthesiology doi: 10.1097/ALN.0b013e31829e47fd contributor: fullname: Benzonana – volume: 36 start-page: 1327 year: 2013 ident: 2021080915435765800_R7 article-title: Comparison of the effects of desflurane and propofol anesthesia on the inflammatory response and s100β protein during coronary artery bypass grafting. publication-title: Inflammation doi: 10.1007/s10753-013-9671-6 contributor: fullname: Baki – volume: 65 start-page: 557 year: 1997 ident: 2021080915435765800_R15 article-title: Instrumental variables regression with weak instruments. publication-title: Econometrica doi: 10.2307/2171753 contributor: fullname: Staiger – volume: 831 start-page: 46 year: 2018 ident: 2021080915435765800_R4 article-title: Effects of propofol on cancer development and chemotherapy: Potential mechanisms. publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2018.04.009 contributor: fullname: Jiang – volume: 113 Suppl 1 start-page: i56 year: 2014 ident: 2021080915435765800_R2 article-title: Effect of anaesthetic technique on the natural killer cell anti-tumour activity of serum from women undergoing breast cancer surgery: A pilot study. publication-title: Br J Anaesth doi: 10.1093/bja/aeu200 contributor: fullname: Buckley – volume: 37 start-page: 587 year: 2017 ident: 2021080915435765800_R19 article-title: Propofol inhibits the growth and survival of gastric cancer cells in vitro through the upregulation of ING3. publication-title: Oncol Rep doi: 10.3892/or.2016.5218 contributor: fullname: Yang – volume: 66 start-page: 1007 year: 2019 ident: 2021080915435765800_R10 article-title: Correction to: Anesthetic technique and cancer outcomes: A meta-analysis of total intravenous versus volatile anesthesia. publication-title: Can J Anaesth doi: 10.1007/s12630-019-01381-0 contributor: fullname: Yap – volume: 26 start-page: 414 year: 2015 ident: 2021080915435765800_R27 article-title: Definition and evaluation of the monotonicity condition for preference-based instruments. publication-title: Epidemiology doi: 10.1097/EDE.0000000000000279 contributor: fullname: Swanson – volume: 27 start-page: 476 year: 2017 ident: 2021080915435765800_R11 article-title: Validity of diagnoses, procedures, and laboratory data in Japanese administrative data. publication-title: J Epidemiol doi: 10.1016/j.je.2016.09.009 contributor: fullname: Yamana – volume: 35 start-page: 1311 year: 2015 ident: 2021080915435765800_R3 article-title: Effect of anaesthetic technique on immune cell infiltration in breast cancer: A follow-up pilot analysis of a prospective, randomised, investigator-masked study. publication-title: Anticancer Res contributor: fullname: Desmond – volume: 37 start-page: 2611 year: 2017 ident: 2021080915435765800_R20 article-title: Propofol suppresses LPS-induced nuclear accumulation of HIF-1α and tumor aggressiveness in non-small cell lung cancer. publication-title: Oncol Rep doi: 10.3892/or.2017.5514 contributor: fullname: Yang – volume: 42 start-page: 19 year: 2017 ident: 2021080915435765800_R21 article-title: Outcomes of cancer surgery after inhalational and intravenous anesthesia: A systematic review. publication-title: J Clin Anesth doi: 10.1016/j.jclinane.2017.08.001 contributor: fullname: Soltanizadeh – volume: 11 start-page: 1141 year: 2018 ident: 2021080915435765800_R24 article-title: Effects of propofol-based total intravenous anesthesia on gastric cancer: A retrospective study. publication-title: Onco Targets Ther doi: 10.2147/OTT.S156792 contributor: fullname: Zheng – volume: 130 start-page: 31 year: 2019 ident: 2021080915435765800_R23 article-title: Total intravenous anesthesia versus inhalation anesthesia for breast cancer surgery: A retrospective cohort study. publication-title: Anesthesiology doi: 10.1097/ALN.0000000000002491 contributor: fullname: Yoo – volume: 119 start-page: 251 year: 2014 ident: 2021080915435765800_R25 article-title: The choice of anaesthetic–sevoflurane or propofol–and outcome from cancer surgery: A retrospective analysis. publication-title: Ups J Med Sci doi: 10.3109/03009734.2014.922649 contributor: fullname: Enlund – volume: 15 start-page: 6703 year: 2014 ident: 2021080915435765800_R9 article-title: Influence of propofol, isoflurane and enflurance on levels of serum interleukin-8 and interleukin-10 in cancer patients. publication-title: Asian Pac J Cancer Prev doi: 10.7314/APJCP.2014.15.16.6703 contributor: fullname: Liu |
SSID | ssj0007538 |
Score | 2.385459 |
Snippet | Background
Previous experimental and clinical studies have shown that anesthetic agents have varying effects on cancer prognosis; however, the results were... BACKGROUNDPrevious experimental and clinical studies have shown that anesthetic agents have varying effects on cancer prognosis; however, the results were... |
SourceID | proquest crossref |
SourceType | Aggregation Database |
StartPage | 764 |
Title | Volatile versus Total Intravenous Anesthesia for Cancer Prognosis in Patients Having Digestive Cancer Surgery |
URI | https://search.proquest.com/docview/2442844750 |
Volume | 133 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NbxMxELVCuXBBIECULxmJW7Ql3vV-HaMCCpRWSKSonFZ21lFWpbtVdvcAv4sfyIxn7SRthSg5bCIrshLP0_h5PPOGsTdA2kyYhmVQTowMpMZG7iivrfNYK7yISW0tzPFJMjuVn87is9Ho91bWUt_pg8WvG-tK_seqMAZ2xSrZW1jWTwoD8BnsC0-wMDz_ycbfGsxk-2HGmFvRt-N501npjA57Clnt1Sl4MqB4baVsPuEh2niN1QGYX1fZXNgvpKzajmfKBhfoygkTioZvf71eOe2nJQUnYKkYmEHFycsVZt_66MIxEFTbqGl8pGp13mzGu7anhtnVujmvPIz6dlVdUIZB9bNZVaUH3nfV9rWiOPAMxpvtgAWcTl3q28YJR0E0oXLkAzP43RAOs4KaqHjHTBIZAwLllptNSfl82LFTaoZybTMgkeHp5xMSqRxekSR9qF3t7St7os9UdHf0MEtxdZY77G4I7g0TCd99PPL7PxwAM9enEf-mK9jM07c3_ZZdQrTLByzJmT9g94fTCZ8S1B6ykakfsQsHM04w4xZmfAtmfAMzDjDjBBzuYcarmjuYcYIZ9zBz3x5g9pidfng_P5wFQ5eOYIGdzgKZ5MkiToXQOapJSiUUUESpQ6WADkZxqUollyYx6WQRLSUsjoD3DHYKk8XahNETtlc3tXnKeBYKLZUWucSwRZlkWiuYallGQpVJLvZZ4JaquCQxluJvBtpnr916FuA18SpM1QaWpQBSC7xMAl1-dss5n7N7G1C_YHvdujcvgZd2-pWFwR-QJYhc |
link.rule.ids | 315,783,787,27938,27939 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Volatile+versus+Total+Intravenous+Anesthesia+for+Cancer+Prognosis+in+Patients+Having+Digestive+Cancer+Surgery&rft.jtitle=Anesthesiology+%28Philadelphia%29&rft.au=Makito%2C+Kanako&rft.au=Matsui%2C+Hiroki&rft.au=Fushimi%2C+Kiyohide&rft.au=Yasunaga%2C+Hideo&rft.date=2020-10-01&rft.issn=0003-3022&rft.eissn=1528-1175&rft.volume=133&rft.issue=4&rft.spage=764&rft.epage=773&rft_id=info:doi/10.1097%2FALN.0000000000003440&rft.externalDBID=n%2Fa&rft.externalDocID=10_1097_ALN_0000000000003440 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0003-3022&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0003-3022&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0003-3022&client=summon |